Generation Bio Co reports results for the quarter ended in June - Earnings Summary

Generation Bio

09/08/2022 13:00

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 66 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 62 cents per share.
    * Reported revenue was zero​; analysts expected $1.50
million. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 66 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had risen by 23.6% this
quarter and
gained 14.5% so far this year.
    * The company reported a quarterly loss of $37.93 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $23.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 12:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.62          -0.66          Missed
 Mar. 31 2022      -0.52          -0.61          Missed
 Dec. 31 2021      -0.57          -0.54          Beat
 Sep. 30 2021      -0.56          -0.56          Met